课题基金 / 基金详情

Pharmacogenomics of aromatase inhibitors (AIs): Building the framework for personalized AI therapy for breast cancer

芳香酶抑制剂 (AI) 的药物基因组学：构建乳腺癌个性化 AI 治疗框架

批准号：

317854

负责人：

Borrie Adrienne E

金额：

$7.65万

依托单位：

University of Western Ontario

依托单位国家：

加拿大

项目类别：

Studentship Programs

财政年份：

2014

资助国家：

加拿大

项目状态：

已结题

起止时间：

2014-10-01 至 2017-10-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=317854&lang=en

关键词：

Aromatase Inhibitors Breast Cancer Chemotherapy Clinical Pharmacology Drug Safety And Effectiveness Genetic Markers Mass Spectrometry Personalized Medicine Pharmacogenetics Pharmacokinetics

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Breast cancer is the most common cancer and the second leading cause of cancer-related deaths among Canadian women. This disease can also occur in men, but is relatively rare. The use of aromatase inhibitors to prevent the recurrence of disease has become

期刊论文(0)

专著(0)

科研奖励(0)

会议论文